You are here

Cancer Discov DOI:10.1158/2159-8290.CD-22-1230

A ubiquitination cascade regulating the integrated stress response and survival in carcinomas.

Publication TypeJournal Article
Year of Publication2022
AuthorsCervia, LD, Shibue, T, Borah, AA, Gaeta, B, He, L, Leung, L, Li, N, Moyer, SM, Shim, BH, Dumont, N, Gonzalez, A, Bick, NR, Kazachkova, M, Dempster, JM, Krill-Burger, JMichael, Piccioni, F, Udeshi, ND, Olive, ME, Carr, SA, Root, DE, McFarland, JM, Vazquez, F, Hahn, WC
JournalCancer Discov
Date Published2022 Dec 28

Systematic identification of signaling pathways required for the fitness of cancer cells will facilitate the development of new cancer therapies. We used gene essentiality measurements in 1,086 cancer cell lines to identify selective co-essentiality modules and found that a ubiquitin ligase complex composed of UBA6, BIRC6, KCMF1 and UBR4, which is required for the survival of a subset of epithelial tumors that exhibit a high degree of aneuploidy. Suppressing BIRC6 in cell lines that are dependent on this complex led to a substantial reduction in cell fitness in vitro and potent tumor regression in vivo. Mechanistically, BIRC6 suppression resulted in selective activation of the integrated stress response (ISR) by stabilization of the heme-regulated inhibitor (HRI), a direct ubiquitination target of the UBA6/BIRC6/KCMF1/UBR4 complex. These observations uncover a novel ubiquitination cascade that regulates ISR and highlight the potential of ISR activation as a new therapeutic strategy.


Alternate JournalCancer Discov
PubMed ID36576405